Grail, Inc. (NASDAQ:GRAL - Get Free Report) shares reached a new 52-week high during trading on Thursday . The stock traded as high as $39.48 and last traded at $39.26, with a volume of 1777607 shares. The stock had previously closed at $33.15.
Analysts Set New Price Targets
GRAL has been the subject of several analyst reports. Morgan Stanley began coverage on Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price for the company. Wolfe Research assumed coverage on Grail in a research report on Friday, November 15th. They issued a "peer perform" rating for the company.
Check Out Our Latest Stock Analysis on GRAL
Grail Price Performance
The business's 50-day simple moving average is $23.94 and its 200-day simple moving average is $18.13.
Insider Buying and Selling
In related news, CFO Aaron Freidin sold 30,452 shares of the company's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. This represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Institutional Investors Weigh In On Grail
A number of large investors have recently modified their holdings of the stock. FNY Investment Advisers LLC purchased a new stake in Grail in the fourth quarter worth about $26,000. State of Tennessee Department of Treasury purchased a new stake in Grail in the fourth quarter worth $28,000. Lindbrook Capital LLC purchased a new stake in Grail in the fourth quarter worth $28,000. Sterling Capital Management LLC purchased a new position in Grail during the fourth quarter valued at $29,000. Finally, Wellington Shields Capital Management LLC purchased a new position in Grail during the fourth quarter valued at $33,000.
About Grail
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
